Ann: BIT225 EFFECTIVE AGAINST ESTABLISHED SARS-CoV-2 IN ANIMALS, page-66

Agree to a point. Hopefully cash won't be an issue end of this month but over the last 14 it has been tight. I think they were focused on the feedback of fda before going down possibly wrong avenues based on what a group thinks the fda want to know.

Burning thru small reserves for ok outcomes but not progressing with fda because they got it wrong could have been fatal to the company and then copious amounts of more knitting posts.
I fear that more than anything at this point, as I am sure many would agree this has been a great day for bit and everyone for that matter.